Both in R&D — Physical & Biological Sciences
Medpace Holdings vs IB Acquisition
Over the past year MEDP returned +9.4% and IBAC returned +3.7%; their daily moves had a correlation of -0.01.
MEDP +9.4% IBAC +3.7%Growth of $1, one year, split-adjusted
| Metric | MEDP | IBAC |
|---|---|---|
| Price | $656.77 | $10.81 |
| Market cap | $18.37B | $54.1M |
| Today | −1.01% | −0.46% |
| 1 month | +8.9% | −0.6% |
| 6 months | +53.9% | −0.2% |
| Year to date | +16.9% | +3.0% |
| 1 year | +10.6% | — |
| Revenue growth (YoY) | +8.5% | — |
| Gross margin | 31.3% | — |
| Net margin | 19.2% | — |
| P/E (TTM) | 35.5× | — |
| Price / sales | 6.5× | — |
| Net cash | $705.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 29.7% | 20.1% |
| Short % of float | 7.2% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).